{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:09:47Z","timestamp":1789513787499,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T00:00:00Z","timestamp":1407369600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00262-014-1589-9","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T08:22:05Z","timestamp":1407313325000},"page":"1189-1197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4+ T regulatory cells"],"prefix":"10.1007","volume":"63","author":[{"given":"Walter Moises Tobias","family":"Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Raphaeli","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi H.","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Bruscato","family":"Bortoluzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar Gil","family":"Rizzatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djordje","family":"Atanackovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Wally Braga","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,7]]},"reference":[{"key":"1589_CR1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","volume":"138","author":"G Pratt","year":"2007","unstructured":"Pratt G, Goodyear O, Moss P (2007) Immunodeficiency and immunotherapy in multiple myeloma. Br J Haematol 138:563\u2013579. doi: 10.1111\/j.1365-2141.2007.06705.x","journal-title":"Br J Haematol"},{"key":"1589_CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2005-08-3101","volume":"107","author":"RH Prabhala","year":"2006","unstructured":"Prabhala RH, Neri P, Bae JE, Tassone J, Shammas MA, Allam CK, Daley JF, Chauhan D, Blanchard E, Thatte HS, Anderson KC, Munshi NC (2006) Dysfunctional T regulatory cells in multiple myeloma. Blood 107:301\u2013304. doi: 10.1182\/blood-2005-08-3101","journal-title":"Blood"},{"key":"1589_CR3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm0804-801","volume":"10","author":"A O\u2019Garra","year":"2004","unstructured":"O\u2019Garra A, Vieira P (2004) Regulatory T cells and mechanisms of immune system control. Nat Med 10:801\u2013805. doi: 10.1038\/nm0804-801","journal-title":"Nat Med"},{"key":"1589_CR4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fimmu.2013.00190","volume":"4","author":"DO Adeegbe","year":"2013","unstructured":"Adeegbe DO, Nishikawa H (2013) Natural and induced T regulatory cells in cancer. Front Immunol 4:190. doi: 10.3389\/fimmu.2013.00190","journal-title":"Front Immunol"},{"key":"1589_CR5","doi-asserted-by":"crossref","first-page":"20410","DOI":"10.1073\/pnas.0810114105","volume":"105","author":"J Yuan","year":"2008","unstructured":"Yuan J, Gnjatic S, Li H, Powel S, Gallardo HF, Ritter E, Ku GY, Jungbluth AA, Segal NH, Rasalan TS, Manukian G, Xu Y, Roman RA, Terzulli SL, Heywood M, Pogoriler E, Ritter G, Old LJ, Allison JP, Wolchok J (2008) CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proc Natl Acad Sci USA 105:20410\u201320415. doi: 10.1073\/pnas.0810114105","journal-title":"Proc Natl Acad Sci USA"},{"key":"1589_CR6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.leukres.2010.11.010","volume":"35","author":"R Gupta","year":"2011","unstructured":"Gupta R, Ganeshan P, Hakim M, Verma R, Sharma A (2011) Significantly reduced regulatory T cell population in patients with untreated multiple myeloma. Leuk Res 35:874\u2013878. doi: 10.1016\/j.leukres.2010.11.010","journal-title":"Leuk Res"},{"key":"1589_CR7","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2005-09-3671","volume":"107","author":"M Beyer","year":"2006","unstructured":"Beyer M, Kochanek M, Giese T, Endl E, Weihrauch MR, Knolle PA, Classen S, Schultze JL (2006) In vivo peripheral expansion of naive CD4+ CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. Blood 107:3940\u20133949. doi: 10.1182\/blood-2005-09-3671","journal-title":"Blood"},{"key":"1589_CR8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2008.07530.x","volume":"144","author":"S Feyler","year":"2009","unstructured":"Feyler S, Von Lilienfeld-Toal M, Jarmin S, Marles L, Rawstron A, Ashcroft AJ, Owen RG, Selby PJ, Cook G (2009) CD4+CD25+FoxP3+ regulatory T cells are increased whilst CD3+CD4\u2212CD8\u2212\u03b1\u03b2TCR+ double negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden. Br J Haematol 144:686\u2013695. doi: 10.1111\/j.1365-2141.2008.07530.x","journal-title":"Br J Haematol"},{"key":"1589_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","volume":"29","author":"XO Yang","year":"2008","unstructured":"Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, Shah B, Chang SH, Schluns KS, Watowich SS, Feng XH, Jetten AM, Dong C (2008) Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29:44\u201356. doi: 10.1016\/j.immuni.2008.05.007","journal-title":"Immunity"},{"key":"1589_CR10","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1182\/blood-2009-10-246660","volume":"115","author":"RH Prabhala","year":"2010","unstructured":"Prabhala RH, Pelluru D, Fulciniti M, Prabhala HK, Nanjappa P, Song W, Pai C, Amin S, Tai YT, Richardson PG, Ghobrial IM, Treon SP, Daley JF, Anderson KC, Kutok JL, Munshi NC (2010) Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma. Blood 115:5385\u20135392. doi: 10.1182\/blood-2009-10-246660","journal-title":"Blood"},{"key":"1589_CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","volume":"28","author":"XO Yang","year":"2008","unstructured":"Yang XO, Pappu B, Nurieva R, Akimzhanov A, Kang SH, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns K, Watowich SS, Tian Q, Jetten AM, Dong C (2008) TH17 lineage differentiation is programmed by orphan nuclear receptors ROR\u03b1 and ROR\u03b3. Immunity 28:29\u201339. doi: 10.1016\/j.immuni.2007.11.016.11","journal-title":"Immunity"},{"key":"1589_CR12","doi-asserted-by":"crossref","first-page":"e45115","DOI":"10.1371\/journal.pone.0045115","volume":"7","author":"L Li","year":"2012","unstructured":"Li L, Patsoukis N, Petkova V, Boussiotis VA (2012) Runx1 and runx3 are involved in the generation and function of highly suppressive IL-17-producing T regulatory cells. PLoS ONE 7:e45115. doi: 10.1371\/journal.pone.0045115","journal-title":"PLoS ONE"},{"key":"1589_CR13","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood-2008-03-143222","volume":"112","author":"KM Dhodapkar","year":"2008","unstructured":"Dhodapkar KM, Barbuto S, Matthews P, Kukreja A, Mazumder A, Vesole D, Jagannath S, Dhodapkar MV (2008) Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma. Blood 112:2878\u20132885. doi: 10.1182\/blood-2008-03-143222","journal-title":"Blood"},{"key":"1589_CR14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749\u2013757","journal-title":"Br J Haematol"},{"key":"1589_CR15","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blad\u00e9 J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412\u20133420. doi: 10.1200\/JCO.2005.04.242","journal-title":"J Clin Oncol"},{"key":"1589_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2008.12.022","volume":"278","author":"RS Felix","year":"2009","unstructured":"Felix RS, Colleoni GW, Caballero OL, Yamamoto M, Almeida MS, Andrade VC, de Chauffaille ML, Silva WA Jr, Begnami MD, Soares FA, Simpson AJ, Zago MA, Vettore AL (2009) SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis. Cancer Lett 278:41\u201348. doi: 10.1016\/j.canlet.2008.12.022","journal-title":"Cancer Lett"},{"issue":"1","key":"1589_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.2004.02502.x","volume":"137","author":"H Ayukawa","year":"2004","unstructured":"Ayukawa H, Matsubara T, Kaneko M, Hasegawa M, Ichiyama T, Furukawa S (2004) Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection. Clin Exp Immunol 137(1):151\u2013155. doi: 10.1111\/j.1365-2249.2004.02502.x","journal-title":"Clin Exp Immunol"},{"key":"1589_CR18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3343\/kjlm.2011.31.4.231","volume":"31","author":"HW Moon","year":"2011","unstructured":"Moon HW, Kim BH, Park CM, Hur M, Yun YM, Kim SY, Lee MH (2011) CD4+ CD25highFoxP3+ regulatory T-cells in hematologic diseases. Korean J Lab Med 31:231\u2013237. doi: 10.3346\/jkms.2012.27.9.1009","journal-title":"Korean J Lab Med"},{"key":"1589_CR19","first-page":"2","volume":"8","author":"VC Andrade","year":"2008","unstructured":"Andrade VC, Vettore AL, Felix RS, Almeida MS, Carvalho F, Oliveira JS, Chauffaille ML, Andriolo A, Caballero OL, Zago MA, Colleoni GW (2008) Prognostic impact of cancer\/testis antigen expression in advanced stage multiple myeloma patients. Cancer Immun 8:2","journal-title":"Cancer Immun"},{"key":"1589_CR20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408. doi: 10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"1589_CR21","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","volume":"114","author":"I Kryczek","year":"2009","unstructured":"Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, Chang A, Coukos G, Liu R, Zou W (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114:1141\u20131149. doi: 10.1182\/blood-2009-03-208249","journal-title":"Blood"},{"key":"1589_CR22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2006-02-002774","volume":"108","author":"M Beyer","year":"2006","unstructured":"Beyer M, Schultze JL (2006) Regulatory T cells in cancer. Blood 108:804\u2013811. doi: 10.1182\/blood-2006-02-002774","journal-title":"Blood"},{"key":"1589_CR23","doi-asserted-by":"crossref","unstructured":"Pessoa de Magalh\u00e3es RJ, Vidriales MB, Paiva B, Fernandez-Gimenez C, Garc\u00eda-Sanz R, Mateos MV, Gutierrez NC, Lecrevisse Q, Blanco JF, Hern\u00e1ndez J, de las Heras N, Martinez-Lopez J, Roig M, Costa ES, Ocio EM, Perez-Andres M, Maiolino A, Nucci M, De La Rubia J, Lahuerta JJ, San-Miguel JF, Orfao A, Spanish Myeloma Group (GEM), Grupo Castellano-Leones de Gammapatias Monoclonales, cooperative study groups (2013) Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry. Haematologica 98:79\u201386. doi: 10.3324\/haematol.2012.067272","DOI":"10.3324\/haematol.2012.067272"},{"key":"1589_CR24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","volume":"19","author":"SE Allan","year":"2007","unstructured":"Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19:345\u2013354. doi: 10.1093\/intimm\/dxm014","journal-title":"Int Immunol"},{"key":"1589_CR25","doi-asserted-by":"crossref","first-page":"e13267","DOI":"10.1371\/journal.pone.0013267","volume":"5","author":"J Liu","year":"2010","unstructured":"Liu J, Lluis A, Illi S, Layland L, Olek S, von Mutius E, Schaub B (2010) T regulatory cells in cord blood\u2014FOXP3 demethylation as reliable quantitative marker. PLoS ONE 5:e13267. doi: 10.1371\/journal.pone.0013267","journal-title":"PLoS ONE"},{"key":"1589_CR26","doi-asserted-by":"crossref","first-page":"e2639","DOI":"10.1371\/journal.pntd.0002639","volume":"8","author":"C Saini","year":"2014","unstructured":"Saini C, Ramesh V, Nath I (2014) Increase in TGF-\u03b2 secreting CD4+CD25+ FOXP3+ T regulatory cells in anergic lepromatous leprosy patients. PLoS Negl Trop Dis 8:e2639. doi: 10.1371\/journal.pntd.0002639","journal-title":"PLoS Negl Trop Dis"},{"key":"1589_CR27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","volume":"108","author":"K Rezvani","year":"2006","unstructured":"Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, Zeilah J, Keyvanfar K, Montero A, Hensel N, Kurlander R, John Barrett A (2006) High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108:1291\u20131297. doi: 10.1182\/blood-2006-02-003996","journal-title":"Blood"},{"key":"1589_CR28","doi-asserted-by":"crossref","unstructured":"HungriaVT, Maiolino A, Martinez G, Colleoni GW, Coelho EO, Rocha L, Nunes R, Bittencourt R, Oliveira LC, Faria RM, Pasquini R, Magalh\u00e3es SM, Souza CA, Pinto Neto JV, Barreto L, Andrade E, Portella MS, Bolejack V, Durie BG, International Myeloma Working Group Latin America (2008) Confirmation of the utility of the international staging system and identification of a unique pattern of disease in Brazilian patients with multiple myeloma. Haematologica 93(5):791\u2013792. doi: 10.3324\/haematol.11637","DOI":"10.3324\/haematol.11637"},{"key":"1589_CR29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/bjc.2011.575","volume":"106","author":"K Giannopoulos","year":"2012","unstructured":"Giannopoulos K, Kaminska W, Hus I, Dmoszynska A (2012) The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma. Br J Cancer 106:546\u2013552. doi: 10.1038\/bjc.2011.575","journal-title":"Br J Cancer"},{"issue":"10","key":"1589_CR30","doi-asserted-by":"crossref","first-page":"e47077","DOI":"10.1371\/journal.pone.0047077","volume":"7","author":"KRM Raja","year":"2012","unstructured":"Raja KRM, Rihova L, Zahradova L, Klincova M, Penka M, Hajek R (2012) Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma. PLoS ONE 7(10):e47077. doi: 10.1371\/journal.pone.004707","journal-title":"PLoS ONE"},{"key":"1589_CR31","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/j.1349-7006.2010.01624.x","volume":"101","author":"T Maruyama","year":"2010","unstructured":"Maruyama T, Kono K, Mizukami Y, Kawaguchi Y, Mimura K, Watanabe M, Izawa S, Fujii H (2010) Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer. Cancer Sci 101:1947\u20131954. doi: 10.1111\/j.1349-7006.2010.01624.x","journal-title":"Cancer Sci"},{"key":"1589_CR32","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM (2003) Conversion of peripheral CD4+ CD25\u2212 na\u00efve T cells to CD4+ CD25+ regulatory T cells by TGF-\u03b2 induction of transcription factor Foxp3. J Exp Med 198:1875\u20138186. doi: 10.1084\/jem.20030152","journal-title":"J Exp Med"},{"key":"1589_CR33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1265","volume":"6","author":"K Kretschmer","year":"2005","unstructured":"Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:1219\u20131227. doi: 10.1038\/ni1265","journal-title":"Nat Immunol"},{"key":"1589_CR34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","volume":"453","author":"L Zhou","year":"2008","unstructured":"Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR (2008) TGF-\u03b2-induced Foxp3 inhibits TH17 cell differentiation by antagonizing ROR\u03b3t function. Nature 453:236\u2013240. doi: 10.1038\/nature06878","journal-title":"Nature"},{"key":"1589_CR35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485\u2013517. doi: 10.1146\/annurev.immunol.021908.132710","journal-title":"Annu Rev Immunol"},{"key":"1589_CR36","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1158\/1078-0432.CCR-12-2177","volume":"19","author":"T Guichelaar","year":"2013","unstructured":"Guichelaar T, Emmelot ME, Rozemuller H, Martini B, Groen RW, Storm G, Lokhorst HM, Martens AC, Mutis T (2013) Human regulatory T cells do not suppress the antitumor immunity in the bone marrow: a role for bone marrow stromal cells in neutralizing regulatory T cells. Clin Cancer Res 19:1467\u20131475. doi: 10.1158\/1078-0432.CCR-12-2177","journal-title":"Clin Cancer Res"},{"key":"1589_CR37","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1182\/blood-2008-12-195354","volume":"113","author":"MD Sharma","year":"2009","unstructured":"Sharma MD, Hou DY, Liu Y, Koni PA, Metz R, Chandler P, Mellor AL, He Y, Munn DH (2009) Indoleamine 2,3-dioxygenase controls conversion of Foxp3 Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 113:6102\u20136111. doi: 10.1182\/blood-2008-12-195354","journal-title":"Blood"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-014-1589-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-014-1589-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-014-1589-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:13:13Z","timestamp":1551208393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-014-1589-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,7]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1589"],"URL":"https:\/\/doi.org\/10.1007\/s00262-014-1589-9","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,7]]}}}